Trials Sponsors Conditions Drugs Pricing

Conditions

Postoperative Nausea and Vomiting

Keywords

postoperative nausea and vomitingheart rate variabilitypropofolsevoflurane

Outcome Measures

Primary Outcomes (1)

heart rate variability in recovery room
Postoperative heart rate variability measuring at recovery room Frequency domain result: total power, low frequency power, high frequency power, Low frequency/high frequency power ratio
within 1 hour

Secondary Outcomes (3)

Postoperative nausea vomiting impact scale
48 hours after anesthesia
The incidence of postoperative nausea and vomiting
48 hours after anesthesia
Patient's satisfaction about postoperative nausea and vomiting
48 hours after anesthesia

Study Arms (2)

Propofol

General anesthesia using propofol infusion

Drug: Propofol

Sevoflurane

General anesthesia using sevoflurane

Drug: Sevoflurane

Interventions

PropofolDrug

General anesthesia using propofol infusion

Also known as: Propofol infusion

Propofol

SevofluraneDrug

General anesthesia using sevoflurane

Also known as: Sevoflurane inhalation

Eligibility Criteria

Age20 Years - 50 Years

Sexfemale(Gender-based eligibility)

Gender Eligibility DetailsInclude only mathces self-representation of gender identity and biological sex

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

20\~50 years old female patients who scheduled breast surgery under general anesthesia

You may qualify if:

Sponsors & Collaborators

Ajou University School of Medicine
Otherlead

Study Sites (1)

Ajou university school of medicine

Suwon, Gyeonggi-do, 16499, South Korea

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

PropofolSevoflurane

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, Aromatic

Study Officials

In Kyong Yi, MD
Ajou University School of Medicine
PRINCIPAL INVESTIGATOR

Enrollment

40 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: assistant professor

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 14, 2020

Study Start

October 17, 2020

Actual (reported)

Heart Rate Variability and Postoperative Nausea Vomiting

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (2)

Propofol

Sevoflurane

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (2)

Propofol

Sevoflurane

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations